InterVene Inc. is involved in addressing Chronic Venous Insufficiency (CVI), providing treatment options that include lifestyle modifications, compression therapy, and medications, with a focus on managing chronic venous flow obstruction and its complications.

InterVene Inc.

InterVene, Inc. | 1,341 followers on LinkedIn. Developing interventional technologies to treat and prevent severe, complex venous diseases | InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases.
 
The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use.

Abha Chinubhai

President, Sonoma Medical Consultants

Mel Schatz

Co-Founder/CEO, Throne: Revolutionizing public bathrooms

Fletcher Wilson

Abraham A Van Scoit

InterVene, Inc.

InterVene, Inc. is excited to join a select group of medical device companies presenting innovative technologies at #TheVEINS24 Innovation Summit in Las Vegas this Sunday (11/3/2024). Kush Desai , MD will present InterVene's #Recana (formerly Chronus) system, currently in development for recanalizing chronic and postthrombotic (PT) venous occlusion and obstruction. Recana's design facilitates treatment in cases of chronic in-stent restenosis (ISR) and late percutaneous mechanical thrombectomy (PMT) for chronic tissue and obstructed and occluded venous stents. Dr. Desai takes the stage from 7:22-7:33 am during the Blue Sky Breakfast. Hope to see you there! #VIVA24 #chronicvenousinsufficiency #CVI #deepvenousstenting #deepveinthrombosis #DVT Jeff Elkins Catherine Matthes Jay Schmelter Andrew Kleiboeker

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 7, 2024 3:44 AM	ac7951ed
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 7, 2024 3:44 AM	21a4656a
crunchbase trigger	general	Nov 7, 2024 3:44 AM	e6768474
crunchbase profile	general
li profile	general	Nov 7, 2024 3:44 AM	3048c9c3
translate crunchbase fundingrounds	general
peers	general	Nov 7, 2024 3:44 AM	d7193cec
news basic	general	Nov 7, 2024 3:44 AM	b1ad78be
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

INTE

COM:INTERVENE-MED

InterVene Inc.